| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
RMD
Resmed
|
Jun 04, 2026 | BUY |
Buy
+18.8% avg upside
27 analysts
|
$320.00
59.81% Upside
|
-2.9% |
|
AU:ACL
Australian Clinical Labs Ltd
|
Jun 23, 2025 | BUY |
Hold
+29.1% avg upside
6 analysts
|
$3.60
62.17% Upside
|
· |
|
RCEL
Avita Medical
|
Aug 09, 2024 | BUY |
Strong Buy
+157.3% avg upside
10 analysts
|
— | -55.6% |
|
AU:SIG
Sigma Healthcare Ltd
|
Jun 07, 2023 | HOLD |
Strong Buy
+131.5% avg upside
10 analysts
|
$0.85
69.32% Downside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.